Incorporated in 1994, Maccura Biotechnology Co., Ltd. is a hi-tech limited-liability company committed itself to independent innovation and suitable development in medical device and solutions, with its distinctive strength and leadership in In Vitro Diagnosis (IVD) industry in China. It provides wide ranges of business in IVD from In-Vitro Diagnostic reagents' development, manufacture to marketing and after-sales service. Maccura has established five product and technology development platforms, which encompass clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, and molecular diagnosis. So far, in order to provide customers with best-quality products, Maccura has been devoted to quality improvement. It has got various quality certifications, including the CMD ISO13485, CQC ISO14001, TUV ISO13485 as well as CE Certification of some products, and obtained the CNAS Medical Reference Laboratory Accreditation. Maccura is also the first enterprise member at IFCC and the first batch to build the enzymatic reference laboratory as an IVD company. Its traceable results of Maccura's diagnostic products have reached the international advanced level. With the joint efforts of 1900+ employees and international-level R&D teams, Maccura now is rapid growing in China's IVD market with 16 subsidiaries and 13 branch offices across Mainland China. Maccura firmly and persistently fulfills its mission that Science and Technology Serve Human Health by its outstanding products and services for its domestic and overseas customers.